Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow–derived counterparts

Journal of Tissue Engineering

Volumn 7, Issue , 2016, Pages

  Blashki, Daniel ^a,b   Murphy, Matthew B ^a,c   Ferrari, Mauro ^c   Simmons, Paul J ^a   Tasciotti, Ennio ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

bone marrow; bone regeneration; colony forming unit fibroblasts; cortical bone; mesenchymal stem cell; prospective isolation; Stem cell; tissue engineering

Indexed keywords

BONE; CELL ENGINEERING; CLONE CELLS; CLONING; FIBROBLASTS; SCAFFOLDS (BIOLOGY); STEM CELLS;

BONE MARROW; BONE REGENERATION; COLONY FORMING UNITS; COLONY FORMING UNIT–FIBROBLAST; CORTICAL BONE; MESENCHYMAL STEM CELL; PROSPECTIVE ISOLATION; PROSPECTIVES; STEM-CELL; TISSUES ENGINEERINGS;

CELL CULTURE;

ALKALINE PHOSPHATASE; CD18 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; MOLECULAR SCAFFOLD; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CARTILAGE; CELL STRUCTURE; CLONAL VARIATION; COLONY FORMING UNIT; CONTROLLED STUDY; CORTICAL BONE; DEVELOPMENTAL BIOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENOTYPE PHENOTYPE CORRELATION; HISTOLOGY; IMMUNOPHENOTYPING; INCIDENCE; MALE; MESENCHYMAL STEM CELL; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 85029729664     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731416661196     Document Type: Article

References (30)

1. Friedenstein AJ, Petrakova KV, Kurolesova AI. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6(2): 230–247.
2. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9(5): 641–650.
3. Pittenger MF, Mackay AM, Beck SC. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143–147.
4. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8(3): 301–316.
5. Meirelles LDS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119(11): 2204–2213.
6. + perivascular cells and fibroblasts. Exp Hematol 2008; 36(5): 642–654.
7. Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013; 45: e54.
8. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28(3): 585–596.
9. Dominici M, Le Blanc K, Mueller I. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315–317.
10. Corradetti B, Taraballi F, Powell. Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate. Stem Cells and Development 2014; 24(9): 1112–1123.
11. Brouard N, Driessen R, Short B. G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving osteoclast-mediated bone resorption. Stem Cell Res 2010; 5(1): 65–75.
12. Short BJ, Brouard N, Simmons PJ. Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol Biol 2009; 482: 259–268.
13. Murphy MB, Blashki D, Buchanan RM. Engineering a better way to heal broken bones. Chem Eng Prog 2010; 106(11): 37–43.
14. Patel DM, Shah J, Srivastava AS. Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int 2013; 2013: 496218.
15. Prockop DJ, Kota DJ, Bazhanov N. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 2010; 14(9): 2190–2199.
16. Bianco P, Cao X, Frenette PS. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 2013; 19(1): 35–42.
17. Krasnodembskaya A, Song Y, Fang X. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28(12): 2229–2238.
18. Ryan JM, Barry FP, Murphy JM. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm 2005; 2: 8.
19. Law S, Chaudhuri S. Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. Am J Stem Cells 2013; 2(1): 22–38.
20. Baxter MA, Wynn RF, Jowitt SN. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004; 22(5): 675–682.
21. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113(Pt 7): 1161–1166.
22. Suire C, Brouard N, Hirschi K. Isolation of the stromal-vascular fraction of mouse bone marrow markedly enhances the yield of clonogenic stromal progenitors. Blood 2012; 119(11): e86–e95.
23. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25(6): 1384–1392.
24. Gronthos S, Graves SE, Ohta S. The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84(12): 4164–4173.
25. Mitchell JB, McIntosh K, Zvonic S. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006; 24(2): 376–385.
26. Traktuev DO, Merfeld-Clauss S, Li J. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008; 102(1): 77–85.
27. Crisan M, Yap S, Casteilla L. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3(3): 301–313.
28. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 2010; 222(2): 268–277.
29. Murphy M, Blashki D, Buchanan R. Multi-composite bioactive osteogenic sponges featuring mesenchymal stem cells, platelet-rich plasma, nanoporous silicon enclosures, and peptide amphiphiles for rapid bone regeneration. J Funct Biomater 2011; 2(2): 39–66.
30. Fan D, De Rosa E, Murphy MB. Mesoporous silicon-PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering. Adv Funct Mater 2012; 22(2): 282–293.